Click on each picture to be linked to matching website.
SRI International and Stanford University School of Medicine Launch the MISTRAL Collaborative to Innovate Medical Device Development June 29, 2010
SRI International and the Stanford University School of Medicine announced today that they have established the MISTRAL (Multidisciplinary Initiative for Surgical Technology Research Advanced Laboratory) Collaborative, a program to accelerate the innovation of medical devices and bring them to market faster. A key objective of this program is the effective and safe transformation of innovative medical device ideas into products that will improve the quality and reduce the cost of healthcare in several key areas, such as pediatric medical products, trauma care, telemedicine, and endoscopy.
Research efforts will focus on underserved medical needs, particularly where market factors and regulatory concerns may prevent medical device companies from investing in high risk innovations. Projects already underway include improved surgical devices for newborns, enhanced surgical endoscopic tools with increased dexterity, and a viable alternative to sutures using robotic instruments.....continue reading
Community Lecture for Robot-Assisted Urologic Surgery (Part 4 of 6) – Carol Salem, MD
Carol Salem, MD, urologic oncologic surgeon and medical director of the Scripps Minimally Invasive Robotic Surgery Program, discusses the latest capabilities in robot-assisted urologic surgery and the advantages of robotic surgery vs. traditional open surgery.
Dr. Raveej Singh
LRMC breaks new ground in heartcare Posted: June 29, 2010
Longview Regional Medical Center’s renowned interventional cardiologist Dr. Raveej Singh is the first doctor in East Texas to implement the newly developed FDA approved implantable cardioverter defibrillator (ICD) which utilizes technologically advanced batteries and circuitry making for the smallest (and hence least invasive) footprint in the field of heart care. The implant is also easily rechargeable, and its small size does not include any decrease in durability or power.
The new Fortify ICD packs 40J of energy, which is the highest power store of any currently available ICD. Such a strong energy reserve is especially helpful for patients who have enlarged hearts, low ejection-fraction, advanced heart failure or have a high defibrillation threshold, which means they need a great deal of electricity to shock their ailing hearts back to a normal rhythm in case of failure or heart attack.
Singh has successfully implanted in his patients the Fortify VR, which was developed by St. Jude Medical and provides a sophisticated sensing technology and anti-tachycardia pacing designed to painlessly convert rapid ventricular arrhythmias back to a normal heartbeat, and to do so without a significant, risky delay in the needed therapy for the rhythms that require it. The device also cuts back.....continue reading
‘Robot’ treatment will speed up cancer care in London June 29, 2010
Londoners are to get “robotic” cancer surgery for the first time.
Until now, the hi-tech treatment using machines to cut out tumours was only available for some NHS patients. But the new Imperial Cancer Research UK centre is carrying out trials so that robot surgery will become standard procedure for all patients. More than 200 clinicians and scientists at the centre will also use the latest imaging techniques to identify which drugs work best in treating cancers of the breasts, ovaries, colon and prostate....read more
Robotic Surgery Expert Dr. David B. Samadi Discusses The Benefits Of Surgery For Organ Confined Prostate Cancer Posted: June 29, 2010
According to a major recent study, appearing in the July 27 issue of the “Journal of Clinical Oncology,” there is a definite downstaging trend for prostate cancer. The study, which surveyed almost 13,000 American men who had a radical prostatectomy (surgical removal of a cancerous prostate gland) between 1987 and 2005, found that only 12% of them died of the cancer. This is great news, according to Dr. David B. Samadi, Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center in New York City.
“The take-away message of this study shows that radical prostatectomy works well,” says Dr. Samadi, who has successfully treated over 2,000 prostate cancer patients with robotic surgery using the da Vinci robotic technique. As mentioned previously, the results determined that 15 years later, 12 percent had died from cancer, and yet the chances of death by natural causes were 38%, greater than for those with prostate cancer.
Dr. Samadi believes that this downstaging of prostate cancer is due to the increased expertise of surgeons, along with improved patient education and public awareness of the disease. Doctors are detecting cases in earlier stages, when it’s more organ confined. Patients are getting screened regularly and working closely with their doctors to monitor their PSA levels and Gleason scores. Gleason scores are......continue reading
Public to test drive surgical robot June 27, 2010
The public will have the chance to get behind the controls of a surgical robot from noon to 8 p.m. Thursday at the Mount Pleasant Towne Centre. Trident Health System is exhibiting its da Vinci Surgical System and letting individuals "test drive" it. People will be able to move the unit's arms, play with the instruments and experience what surgeons see and feel when they use the robot to operate.
There also will be a contest to name the robot, where the winner will receive a $100 Visa gift card. The da Vinci Robotic Surgery System was featured on the season finale of "Grey's Anatomy" and on "Good Morning America" and other television shows. For more information about the event or for a physician referral, click here or contact Consult-A-Nurse at 797-FIND (3463). To find out more about the da Vinci Surgical System, visit http://www.tridenthealthsystem.com/
Robotic surgery: How safe is it? From the Orlando Sentinel - Published Friday June 25, 2010
Recent reports of da Vinci operations gone awry because of doctors' inexperience with the new technology have led to concerns that some hospitals' credentialing standards for surgeons who use the robot are too loose.
However, doctors at Orlando Health's Winnie Palmer Hospital and Florida Hospital's Celebration Health, say measures have been taken at their hospitals to ensure patient safety and successful surgical outcomes.
"We're developing strict guidelines for these types of surgeries," said Dr. Jessica Vaught, a gynecologic surgeon who leads Winnie Palmer's robotic surgical training program. "Robotics is an exciting new field, but it's one that needs a lot of regulation.
Last month, a Wall Street Journal article highlighted the case of a botched operation with the da Vinci robot at a New Hampshire hospital to illustrate problems that have arisen from inexperienced doctors using the machine. A follow-up story referred to a case in which a 42-year-old man died following robotic surgery last summer at a Boca Raton, Fla., hospital. An attorney for the man's family said the urologist who operated on him had never before performed the procedure he was attempting with the robot, according to the report.
"These articles highlighted important problems. We agree surgeons need more education. They need more support from the hospital," said urologist Vipul Patel, a world-renowned robotic surgeon who is largely responsible for the development of Florida Hospital's robotics program and its Nicholson Center for Surgical Advancement, which focuses on robotic surgery and training.
Because robotic surgery is still an emerging, albeit fast-growing field, there are no standards for credentialing surgeons to use the machine. That is left to each hospital....continue reading
Pre-emptive pain regimen decreased opioid usage in patients undergoing robotic prostatectomy June 25, 2010
Reporting in the journal Urology, researchers at Thomas Jefferson University have found that a pre-emptive multimodal pain regimen that included pregabalin (Lyrica) decreased the use of opioid analgesics in patients undergoing robotic-assisted laparoscopic radical prostatectomy.
Opioid usage, which involves narcotic pain medications, was significantly less in patients who received the multimodal regimen compared to patients who received a standard postoperative analgesic regimen. The mean opioid dose, which was measured in 'total morphine equivalent dose,' was 75.3 mg for patients who received the standard regimen, versus 49.1 mg for patients who received the multimodal regimen.
'This is the first demonstration of the effectiveness of a pre-emptive pain management protocol using pregabalin in urologic surgery,' said Edouard J. Trabulsi, M.D., associate professor of Urology at Jefferson Medical College of Thomas Jefferson University. 'We think this study paves the way for new pain management protocols...read more
Cancer Research UK launches hi-tech research centre at Imperial Wednesday 23 June 2010
Cancer Research UK Press Release
A new cutting-edge cancer centre dedicated to robotic surgery, cancer imaging and drug discovery is launched today, putting London at the forefront of cancer research. The Imperial Cancer Research UK Centre will see more than 200 clinicians and scientists from Imperial College Healthcare NHS Trust and Imperial College London working together to develop breakthrough treatments for the disease.
The Centre is the latest link in a unique chain of centres being launched around the country. Cancer Research UK already supports research at Imperial but is set to increase its contribution to £8 million a year to help develop the Centre.
Scientists at the centre will build on Imperial’s internationally renowned clinical and research strengths. They will develop robotic technology to bring the latest surgical techniques to cancer patients in London. They will also carry out research using the latest imaging techniques to watch cancer drugs at work inside the patient’s body, identifying which treatments work best at an earlier stage....continue reading
Study Finds Robotics Not Always Best For Hysterectomy Success And Recovery June 23, 2010
Women’s Surgery Center data shows outcomes better, costs lower for non-robotic LRH technique.
According to a new study by two leading gynecological specialists at the Women’s Surgery Center in Washington, patients undergoing hysterectomy for benign gynecologic conditions such as fibroids fare better in the hands of a skilled surgeon vs. high-tech robotics.
The study compared surgical outcomes of laparoscopic retroperitoneal hysterectomy (LRH) with those performed by the robotic approach using Da Vinci surgical system (DVSS) for benign gynecologic conditions. The results demonstrated that among other benefits, LRH dramatically reduces operating time, patient costs, and length of hospitalization and recovery for women undergoing hysterectomy.
The research, presented at the 2009 conference of the American Association of Gynecologic Laparoscopists and now under review for publication, involved a retrospective analysis of 139 LRH patients and data from two of the largest DVSS studies to-date.....read more
Kathy Huang, M.D., robotic surgery specialist at New York Hospital Queens.
Robotic Gynecological Surgery Performed for the First Time in Queens, N.Y. June 22, 2010
Seated comfortably at a console viewing a 3-D image of her patient, Kathy Huang, M.D., attending physician, Department of Obstetrics and Gynecology at New York Hospital Queens (NYHQ), performed the first gynecological robotic surgery in Queens on a 37-year-old woman who had excessive uterine bleeding and an ovarian tumor.
The minimally invasive surgery was successful, the patient’s fertility was preserved and the woman was able to go home the same day. As a robotic surgery specialist, Dr. Huang has received advanced training in minimally invasive robotic surgery. Dr. Huang is the only gynecological surgeon in Queens offering robotic surgery to women.
Prior to coming to New York Hospital Queens, Dr. Huang has treated hundreds of women using robotic technology. Since New York Hospital Queens installed the robot in May, Dr. Huang has performed 10 cases—all with excellent outcomes.
“The success of these first robotic cases is a tribute to the experience and skill of Dr. Huang, and the planning and the preparation of her surgical team, said....continue reading
Pre-Clinical In-Vivo Study Highlights Potential for Reduction in Vessel Trauma and Improvements in Efficiency With Hansen Medical's New Vascular Robot June 22, 2010
Vascular Surgeons Report New Vascular Robot May Allow Faster and Less Traumatic Catheter Navigation Compared to Manual Catheterization
(MARKETWIRE via COMTEX) -- Hansen Medical, Inc. (HNSN 2.36, +0.11, +4.89%) announced the successful completion of a pre-clinical in-vivo study evaluating its new vascular robot, which demonstrated improvements in catheter navigation, reductions in vessel trauma during catheter manipulation, and improvements in access time for some vessels, as compared to manual catheter manipulation during endovascular procedures. Results also showed that the company's vascular robot has the potential to standardize catheter navigation, which may lead to more predictable procedures. The early, but encouraging results were presented June 12, 2010 at the Society of Vascular Surgery's 2010 Vascular Annual Meeting in Boston....continue reading
Pascagoula father beats prostate cancer with robotic surgery
June 22, 2010
For Mike Heidelberg, Father's Day was fairly average this year. He spent time working in the yard with his wife of 30 years, Susan, and fishing with his son Michael and daughter Charlotte.
Were it not for daVinci robotics-assisted surgery, the holiday might be different. As with many men, Heidelberg's annual physical and blood work required by his health insurance provider was part of the routine. He scheduled the appointment in January and turned his attention back to the paperwork on his desk. One week later, the 61-year-old businessman wasn't surprised to receive a follow-up phone call from his physician. With a family history of prostate cancer, he knew what the elevated prostate-specific antigen (PSA) count his doctor mentioned probably meant. Heidelberg might have prostate cancer.
The biopsy revealed precancerous cells in his prostate and his urologist, Dr. Mark Lyell, called in Heidelberg and his wife, Susan, to discuss the options. There were four: do nothing; have a radical prostatectomy; schedule radiation therapy; or have daVinci prostatectomy. He chose the daVinci surgery. "I knew what I wanted to do. We needed to get in there and take care of it, and get out," Heidelberg said. "I chose daVinci because Singing River Health System was the first on the coast to have it and I knew it was the best technology available."....continue reading
Chinese market beckons June 21, 2010
MEDICAL TECHNOLOGY: West China Hospital may serve as a gateway for London businesses
The technology that allows London surgeons to operate with robots through tiny incisions could end up prying open the medical market in China for medium-sized Canadian companies.
CSTAR, the Canadian Surgical Technologies and Advanced Robotics centre at London Health Sciences Centre, plans on forming an international company and opening a CSTAR centre at West China Hospital in Chengdu, Sichuan Province.
The initiative builds on an agreement between West China School of Medicine at West China Hospital, one of the largest in Asia, and the University of Western Ontario to exchange faculty and students.
A CSTAR centre in China will provide medium and small North American companies with a base to test and refine their medical devices for the massive Chinese market, John Parker, director of CSTAR, told more than 100 participants at a robotic surgery conference in London Friday....continue reading
Recent Foster's articles relating to robotic surgery have mentioned physicians with whom I work closely, Drs. Rebecca Banaski and Elizabeth Chase. I have watched as they have become pawns in a larger controversy whipped up by a Wall Street Journal reporter. This reporter seems to believe that robotic surgery technology only belongs in large medical centers. Whether intended or not, his mission to fuel this controversy has maligned our community-based medical care.
Our doctors have not been contacted by this paper for their view. Had they been provided that opportunity, they could say little due to confidentiality constraints. Unfortunately, the doctors are unable to correct inaccuracies, which are many.
Garrison Women's Health Center, which is proud to include Dr. Banaski and Dr. Chase, has been an integral part of this community since 1962. Our mission is "Supporting Women with Excellence and Compassion" and our staff and providers live this statement every day.
I have worked for Drs. Banaski and Chase for two years. They are exceptional physicians. Not only are they well-educated and highly skilled, they contribute substantial time and resources to community non- profit agencies. They provide no fee/reduced fee services to local women in need to an extent I have never experienced in twenty years of medical practice management.
There are risks associated with any surgical procedure, robotic or not. Our physicians review both the potential risks and benefits of each surgical option with our patients. Patients meeting the criteria for robotic surgery often benefit from a shorter hospital stay, reduced pain, faster recovery, and decreased blood loss. Robotic surgery can be the very best choice for many patients.
Dr. Banaski and Dr. Chase are skilled surgeons with many hours of advanced training and education and they have a solid track record of excellent outcomes. They, as all our physicians, would not do any procedure if they could not do it safely.
Thank you to all the wonderful people in the community who have given us their support — we are blessed to have so many wonderful patients.
Dr. Mildred Ridgway
GYN Oncologist Uses da Vinci Surgical Robot to Preserve Fertility June 18, 2010
Mississippi's only female Gynecologic OncologistMildred Ridgway, MD is now performing a new procedure at BaptistMedical Center in Jackson, Miss. using the da Vinci® surgical robot to remove uterine fibroids. Removing uterine fibroids is referred to as a myomectomy, or fibroidectomy.
Jackson, MS (Vocus) -- Baptist Medical New Network, a division of Baptist Health Systems in Jackson, Miss., recently posted a video of Mississippi's only female Gynecologic Oncologist Mildred Ridgway, MD performing a minimally invasive way to remove uterine fibroids using the da Vinci® surgical robot. The procedure is often referred to as a myomectomy, or fibroidectomy.
Dr. Ridgway began removing uterine fibroids using the da Vinci in 2009. The case dipicted in the video is of a 33 year-old woman who presented with an enlarged uterus, pelvic pain and excessive bleeding. In an effort to retain her fertility, Dr. Ridgway removed the single isolated fibroid, about the size of a large organge, from the patient's uterus. So, in order to remove the fibroid tumor, Dr. Ridgway used the robot to access the uterus, make an incision, cut the tumor out and sew the uterus back together....continue reading
Botched Operation Using da Vinci Robot Spurs Lawsuit By JOHN CARREYROU, May 25, 2010 Posted: June 17, 2010
A woman whose ureters were accidentally cut during a surgery with the da Vinci robot last year filed a lawsuit against Wentworth-Douglass Hospital in Dover, N.H., and the two surgeons who operated on her.
The suit, which echoes other cases across the country, comes amid concerns that some hospitals' credentialing standards for surgeons who use the cutting-edge machine are too lax.
Some surgeons experienced with the robot, Manufactured by Sunnyvale, Calif.-based Intuitive Surgical Inc, say it requires hundreds of cases to master. Some hospitals have rigorous robotic-training programs, but others let their surgeons use the complex machine unsupervised after just a few cases. Intuitive Surgical pays for a two-day-onlytraining course for two surgeons when a new hospital client buys a robot, but it says further training and credentialing are at hospitals' discretion.
Use of the da Vinci robot by surgeons insufficiently trained on it has been an issue in other cases. In one case last summer, a 42-year-old doctor named Carlos Chiriboga died following a robotic surgery performed at West Boca Medical Center in West Boca Raton, Fla. Darla Keen, an attorney representing Dr. Chiriboga's family, says the urologist who operated on Dr. Chiriboga had never performed the surgery he was attempting with the robot before.
A spokeswoman for West Boca Medical Center said the surgeons who have performed robotic surgery at West Boca have had a solid success rate since they began performing the surgery at the hospital more than two years ago. "The hospital conducted a thorough review of the matter and is confident in the quality of care provided to Dr. Chiriboga," said spokeswoman Rebecca Ayer. For complete story Click here
Scripps Health Performs 1,000 Robotic Surgeries June 15, 2010
In just under three years, surgeons with the Scripps Minimally Invasive Robotic Surgery Program have performed more than 1,000 robot-assisted surgeries, including a wide array of complex urologic, cardiothoracic and gynecologic procedures, as well as oncologic and general surgeries – establishing Scripps as the fastest-growing and most comprehensive robotic surgery program in San Diego.
“This is a tremendous achievement for our program, and we are proud of our continued commitment to our patients,” said Carol Salem, MD, urologic oncology surgeon and medical director of the Scripps Minimally Invasive Robotic Surgery Program. “This accomplishment helps to reaffirm the trust our patients have in our ability to offer them this advanced type of technology.”....read more
Endometriosis? Robotic surgery may not be the answer June 15 2010
Robots may not help doctors do a better job on some surgeries, according to a new study. Surgeons treating women with endometriosis - a chronic condition that affects more than 5 million women and adolescent girls in the U.S. - didn't get better or faster results when they used a robotic system.
With the surgeon alone, "the incision is smaller (and) the manipulations are more controlled," Dr. Ceana Nezhat, an author on the study and the chair of Obstetrics & Gynecology at Northside Hospital in Atlanta, told Reuters Health.
Because the robot lets the surgeon get a better picture of the inside of the body, the authors had expected that surgeries using the robot would go more smoothly than those without it. To test this idea, they looked back at 78 minor surgeries that were done on women with endometriosis - half using the assistance of a robot, half without it.
There was no difference in how much blood patients lost, and there were no complications in either group. But robotic surgeries took longer than non-robotic surgeries by about 40 minutes - 3 hours and 11 minutes compared to 2 hours and 29 minutes, on average. Longer surgeries often mean a more tired surgeon and more chances for things to go wrong.
The robot-surgeon team might not have outperformed the surgeon alone because the procedure was a relatively simple one....continue reading
transoral robotic surgery (TORS): tongue base reduction and supraglottoplasty
Doctors at El Camino Hospital Perform Unprecedented Surgery on Highly Developed Case of Endometriosis June 15, 2010
Surgeons at El Camino Hospital on Wednesday successfully undertook an unprecedented procedure using minimally invasive techniques to treat, as one doctor put it, “one of the most advanced cases of endometriosis I have ever seen.”
The patient, a 36-year-old woman from Portland, Ore., had lost almost all of the function in her left kidney due to severe endometriosis that had involved her major organs, nerves and blood vessels, leading to crippling pain and swelling in her leg. Managing the pain with powerful pain medications, she was told she would have to live that way for the rest of her life – until she was referred to Dr. Camran Nezhat, who collaborated with Dr. Frank Lai and Dr. Ramin Beygui at El Camino Hospital.
Using El Camino Hospital’s state-of-the-art surgical equipment and expertise, the team removed her damaged kidney and treated the endometriosis that had extended into her kidney, uterus, ovaries, bladder, bowel, ureter, blood vessels and nerves. The surgeons collaborated on the operation, with Dr. Beygui, a renowned cardiovascular surgeon and medical director of El Camino Hospital’s cardiac surgery program, collaborating on the vascular portion of the surgery; Dr. Lai, a leading urologist who specializes in robotic and laparoscopic surgery, performing the kidney removal and urology portion; and Dr. Nezhat, one of the world’s foremost experts on the treatment of endometriosis and infertility, performing the endometriosis removal. “This was an extremely difficult and intensive case....continue reading
World Renown Surgeon Presents Viking Systems' 3DHD System at European Congress of Laparoscopy and Robotics
WESTBOROUGH, Mass., Jun 15, 2010 (GlobeNewswire via COMTEX) -- Viking Systems, Inc. (VKNG 0.25, +0.01, +4.17%) announced today that its Next Generation 3DHD Visualization System was presented June 10th at The European Congress of Laparoscopy and Robotics by Dr. Gunter Janetschek, Professor and Chairman, Department of Urology, Medical University Salzburg, as part of his talk "Is there a future beyond 'da Vinci'?"
The context of Dr. Janetschek's presentation was to discuss advancements and possible future of medical technology used in minimally invasive urologic surgery. This included the possible role and benefits of Viking's Next Generation 3DHD Visualization System.
The European Congress of Laparoscopy and Robotics brings together technological advances, education and communication in order to advance knowledge of ongoing research and clinical activities relating to the challenges in laparoscopy and robotics as they relate to urological surgery.
"The invitation by Dr. Janetschek to have Viking Systems provide material for his presentation was quite an honor," said Jed Kennedy, President & CEO of Viking Systems, Inc. who went on to add, "being included in the presentation really drives awareness of the work Viking is doing, the progress 3DHD is making and its promising future in complex minimally invasive surgery."...read more
Dr. Claus Roehrborn uses the dual-console DaVinci Surgical System.
Dallas’s First Scarless Robotic Surgery for Throat Cancers Performed June 15, 2010
Newswise — Head and neck cancer surgeons at UT Southwestern Medical Center performed the area’s first transoral robotic surgery (TORS), a recently approved minimally invasive no-scar procedure to remove tumors in the throat.
The robotic approach allows UT Southwestern surgeons to better view and access lesions from the oral cavity and throat down to the level of the vocal cords, making the technique advantageous for more patients with cancers in these areas. TORS, which requires special training for surgeons, was approved recently by the Food and Drug Administration for benign and cancerous lesions in the back of the throat.
“Transoral robotic surgery is probably the next step in the evolution of head and neck procedures because you have the option to go through the mouth and remove the tumor completely without any external incisions,”said.....continue reading
A Brean Murray Carret & Co. analyst downgraded shares of robotic surgery system maker Intuitive Surgical Inc. on Monday, citing concerns over a slowdown in European spending on health care as nations try to rein in debt.
Analyst Jose Haresco downgraded the stock to "Hold" from "Buy."
"It is common knowledge at this point that Germany and the U.K. are cutting back on the growth of their health care budgets as part of a broader attempt to rein in sovereign debt," he said, in a note to investors. "We would not be surprised to hear of similar efforts in the other major European markets like France and Italy."
He said about 18 percent of the company's install base is in Europe. He added that a slowdown in spending could result in fewer systems being sold. He now expects about 53 systems to be sold in Europe in 2010, down from a prior estimate of 67 systems.
Dr. Ash Tewari
$3 Million Gift Establishes LeFrak Center for Robotic Surgery Posted: June 14, 2010 - (live-PR.com) - NEW YORK (May 28, 2009)
Leading Robotic Urologic Surgeon Dr. Ash Tewari Named Director of Robotic Surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center
A $3 million gift from the Richard S. and Karen LeFrak Charitable Foundation will establish the LeFrak Center for Robotic Surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
The LeFrak Center will focus on robotic treatments for patients with prostate cancer and other urologic conditions, and will support innovative procedures in areas including otolaryngology, obstetrics and gynecology, and ophthalmology. Dr. Ash Tewari, one of the world's foremost robotic urologic surgeons, will lead the new center as the newly appointed director of robotic surgery at NewYork-Presbyterian/Weill Cornell. A dedication ceremony is planned for later this year.
"Robotic surgery is a powerful example of technology's ability to transform patient care, helping patients live longer and more healthful lives," says Dr. Herbert Pardes, president and CEO of NewYork-Presbyterian Hospital. "We are deeply grateful to the LeFrak family for supporting the creation of a dedicated program in this area. Their leadership and generosity will bring an immediate and lasting benefit to patients."...continue reading
Cryosurgery and Robotic Surgery New Treatments for Prostate Cancer
Robotic Surgery and Cryosurgery are new treatments for prostate cancer. Both still involve surgical procedures to treat the tumor but both are less invasive. They allow quicker recovery for patients undergoing these latest treatments compared to the traditional open prostate surgery.
What is Robotic Prostate Surgery? It is also called as Robotic Laparoscopic Prostatectomy. The cancerous gland is also surgically removed just like in traditional prostatectomy. The difference is in how it is done. In traditional prostate surgery, the surgeon makes an incision in the lower abdomen or perineum to remove the cancerous prostate gland. In robotic surgery, the surgeon makes smaller incisions around the navel plus he does the whole procedure through robotic arms. This makes the surgeon move more precisely and with better control.
What are some of its advantages? •Less blood loss during the operation. •The nerve fibers and blood vessels around the prostate gland that are vital for healthy sexual functions are protected from damage because of the accuracy of the movements of the surgeon. •Shorter hospital stay due to faster recuperation compared to the more invasive type of prostatectomy.
Is robotic surgery for every prostate cancer patient? Unfortunately, robotic surgery is only recommended for early stage prostate cancer just like the traditional method of removing the malignant gland.
What is Cryosurgery for Prostate Cancer? Cryosurgery is also known as cryotherapy and cryoablation. In this type of surgery, needles are used to administer gases that can freeze the tumor. The freezing process kills cancerous cells by forming ice crystals inside the cancerous cells until the tumor is frozen and dehydrated. A freezing temperature of -140 degrees Celsius has also been discovered to cause another benefit - the human body is able to produce more anti-bodies that help destroy the cancer.
When is cryosurgery an effective treatment option? It is recommended for: early stage prostate cancer and when radical prostatectomy is out of the question, and the cancer has recurred after radiation and is already resistant to radiation.
What are its benefits? •Shorter hospital stay (the patient can be discharged within the day or stay overnight). •Less post-operation pain with just a little bruising in the perineal area. •Quicker recovery as patient is up and about after the procedure (although strenuous activities are not allowed while the catheter is still inside). •Minimal loss of blood. •Both cryosurgery and robotic surgery as prostate cancer treatment options are not as popular as radiation or chemotherapy. This is because of their newness and lack of comparative studies on survival rates. But in the fight for cancer, all the help a patient can get makes a lot of difference.
New Study Says Men with Low-Grade Prostate Cancer Delay Surgery June 11, 2010
A new study says that men with lower risk prostate cancer are delaying the decision to have surgery. Researchers at Maryland's John Hopkinds Brady Urological Institute have found that men who delay surgery do not have worse outcomes than men who have surgery earlier. These are men who have small, low-grade tumors. Their doctors keep a close watch on the progress and prognosis of these patients in case a more serious or higher grade cancer arises -- in which case surgery may be needed
The findings report that 15-20% of men who were initally low-grade and under doctor survelence will eventually progress to high-grade status and need surgery. Of course, every patient should disucss....read more
MAKO Surgical Corp. to conduct clinical study in Scotland Posted: June 11, 2010
MAKO Surgical Corp. has announced it will conduct clinical studies at the NHS Greater Glasgow and Clyde’s Royal Infirmary and the University of Strathclyde of its state-of-the-art robotic arm for orthopaedic surgery, according to a press release.
The company stated that it is the first time the robotic arm technology it has pioneered will be used outside the United States. The firm has joined forces with orthopedic surgeons from NHS Scotland and leading scientists from the University to establish the multidisciplinary MAKO Centre for Surgical Robotics, which was officially launched on June 3, 2010.
Over the course of the next 3 years, the Centre at the University’s department of bioengineering, together with the participating surgeons at the NHS, will engage in randomised clinical trials of MAKO’s RIO Robotic Arm Interactive Orthopaedic System, which allows surgeons to perform a precise knee resurfacing procedure called MAKOplasty, according to the release...read more
Inside the Robotic Operating Room of the Future
Health care is always going to be a newsworthy issue, but what about futuristic health care? Digital Journal explored the sooner-than-we-think world of robotic medical machines. Digital Journal interviewed the leaders of advanced robotic technology who are adding a realistic sense of touch to surgical robotic tools....read more
In this health video minute on prostate cancer, Dr. Ash Tewari, M.D., M.Ch. (leader in prostate cancer research and surgery) of Cornell Urology discusses open incisions vs. robotic approaches in treating prostate cancer through surgical procedure. Join Dr. Tewari as he explains what it’s like to perform surgery with the use of robotic prostate cancer surgery techniques. Dr. Peter N Schlegel, M.D., F.A.C.S. explains the advantages and disadvantages and discusses a comparison with respect to the prostate cancer outcomes of open incisions and robotic approaches.
Dr. Francis Sutter
Leading U.S. Heart Surgeon to Urge Doctors at International Conference to Embrace Robotic Surgery June 9, 2010
Dr. Francis Sutter to Advance Argument to Minimize Patients' Pain and Recovery Time at June 19th Conference in Beijing
PHILADELPHIA, June 9 /PRNewswire/ -- Dr. Francis Sutter, one of five leaders in the United States in minimally-invasive robotic assisted beating heart coronary bypass surgery has accepted an invitation to speak at the 2010 World Congress of Cardiology and World Heart Federation in Beijing on the topic of robotic heart surgery. Dr. Sutter will tell an audience of his peers on Saturday, June 19th that recovering from heart surgery is hard enough for patients and the world's doctors have a responsibility to learn new techniques that offer patients surgical options making patient recovery and return to everyday activities as easy as possible.
"Unfortunately, more than 99-percent of bypass operations in this country are still performed by cracking the patient's chest open, resulting in unnecessary levels of pain and discomfort and requiring a lengthy recovery time," said Sutter. "My patients live 24/7 lives. Many of them don't have the luxury of slowing down, even for open-heart surgery. I can have them out of the operating room and back to the board room, or other pursuits, in about two weeks; that's one-third of the time it takes for traditional bypass surgery."
The annual World Congress of Cardiology and World Heart Federation is one of the largest meetings held focusing on cardiovascular disease and welcomes thousands of cardiologists and healthcare professionals from over 45 countries.
Dr. Sutter, chief of cardiothoracic surgery at Main Line Health, a premiere hospital network in Philadelphia...read more
Law firm seeking patients harmed by da Vinci surgery at Wentworth-Douglass Hospital June 9, 2010 from fosters.com
DOVER — A law firm wants to know if anyone experienced issues similar to a local woman who is suffering permanent damage after undergoing da Vinci robotic surgery at Wentworth-Douglass Hospital.
The Coolidge Law Firm in Somersworth placed an advertisement in several editions of Foster's Daily Democrat last week, and attorney Peter Mathieu says the ad will run again Thursday through Saturday.
"Have you had DaVinci robotic surgery? Know your legal rights!" says the ad, printed in white over a black box.
The ad came after Sherry Long of Rochester filed suit last month against WDH and two doctors who she says are responsible for inflicting permanent damage when both of her ureters were severed during a hysterectomy on March 2, 2009.
Mathieu said his office has received calls from people who experienced trouble during non-robotic laparoscopic surgery, but "the way it was reported to us the incidences that occurred were accepted risks of surgery." He added, "When you have a trained doctor doing his or her job sometimes damage occurs that can be an accepted risk of surgery. We can distinguish that kind of procedure with the result of surgery from a da Vinci robotic procedure where the doctor is not well trained or undertrained with its use."
Mathieu and David P. Angueira, an attorney with Swartz & Swartz of Boston also handling the case, filed suit in Strafford County Superior Court against WDH and Drs. Rebecca Banaski and Elizabeth Chase.
At the time of the surgery, the suit says, "neither physician was qualified or competent enough to use" the da Vinci robot. According to the suit, Banaski performed the surgery "while under the alleged supervision of" Chase, even though Long "was never informed" that Banaski "had insufficient training, education and experience to perform the operation herself and was going to be assisted and supervised" by Chase.
WDH has defended its use of the da Vinci, maintaining it reduces complications, patients' turnaround times, blood loss and pain because it allows for less invasive surgery. The hospital has yet to have been served with the suit, WDH spokeswoman Noreen Biehl said.
No excuse for da Vinci at WDH Published: June 3, 2010 by fosters.com Posted: June: 9, 2010
I write once again as a follow-up to my Letter of May 13 in order to express my horror at the surgical goings-on at Wentworth-Douglass Hospital. Last week, Foster's reported that a patient, severely injured at the Dover hospital, saw fit to bring a very justified malpractice action against both the hospital and two of its doctors for the careless abuse of the Da Vinci robot. This tragedy should be known to a community "at risk" for competitive "market share" ahead of patient safety will now play out in a court of law and justify my previous warning of "Buyer Beware"!
The cutting of both ureters by an inexperienced surgeon, supervised by another novice at the procedure, is hardly a "routine risk" of gynecologic surgery, as claimed by the hospital spokesperson. There is no excuse for introducing a new and very complicated technology into a small hospital with just over 100 active beds.
How to prevent a repetition of such administrative arrogance should rest with New Hampshire state's Certificate of Need (CON) Board. Here again, however, we find an almost total absence of medical expertise and more concern for the "bottom line." As a former member of the CON Board, I am very familiar with its workings and have just witnessed, at its May 20 meeting, how insensitively all but one of the six attendees related to this Wentworth-Douglass disaster.
Sherry Long of Rochester, the victim of this botched procedure, will deserve all the consideration she warrants from a Strafford County jury. Hopefully, this event may serve as an alert for more strict regulation of out-of-control hospital adventure into what is more properly Mayo Clinic territory.
As Wentworth-Douglass has just received CON approval for a $54 million "renovation and expansion" of its physical plant, one can only wonder how much overtime that leased Da Vinci will be working to pay off those borrowed bonds.
@Letters name:Joseph M. Miller, M.D. @Letters town:Durham
Lawsuit claims Cleveland Clinic botched prostate surgery June 7, 2010
A retired Air Force colonel from the Dayton, Ohio area has filed a lawsuit against the Cleveland Clinic, alleging that a botched prostate surgery at the hospital has left him impotent and incontinent.
At issue is who performed a robotic surgery to remove Col. David Antoon’s cancerous prostate gland — an experienced surgeon or a doctor-in-training. Antoon maintains he signed a consent form authorizing only an experienced physician to perform the surgery, The Plain Dealer reported. However, the lawsuit alleges that the experienced surgeon either wasn’t present for the surgery, or the surgeon merely observed a doctor-in-training perform the procedure.
The Clinic shot back that Antoon’s lawsuit “contains numerous inaccuracies and we plan to fully respond in the course of the litigation.” The statement didn’t address the issue of who performed the surgery.
"We regret Col. Antoon’s outcome, as it was the result of a recognized complication,” the Clinic’s statement said.
In any case, during the surgery, “something went terribly wrong” and Antoon “was rendered incontinent of urine and permanently impotent,” Antoon alleges. Further, the suit alleges that a Clinic ombudsman told Antoon that one of the doctors-in-training said he didn’t recall the experienced surgeon participating in the procedure.
Antoon claims he requested the Clinic provide him with a video recording of his surgery, but his requests have been ignored. The lawsuit charges the hospital and doctors with medical negligence and interference with evidence, among other claims.
Femoral Embolectomy Surgery in India: With Latest Medical Technology June 7, 2010
Femoral embolectomy surgery has become a specialty in India. It combines the latest innovations in medical electronics with experienced surgeons as well as specialists for this surgery. The country has the distinction of providing comprehensive care spanning from basic facilities to the most sophisticated curative technology.
The technology is contemporary and world class and the volumes handled match global benchmarks. They also specialize in offering surgery to high-risk patients with the introduction of innovative techniques like minimally invasive and robotic surgery. Renowned Indian hospital is equipped to handle all phases of diseases from the elementary to the latest clinical procedures.
The success rate at an average of 98.50% is at par with leading medical centers around the world. Leading medical centers in India have sophisticated equipment and investigative facilities. India is fast becoming the world’s first choice destination for femoral embolectomy surgery.
Surgeons should practice on computers, not people By Curt Rawley, Chairman and CEO, SensAble Technologies; February 18, 2010 Posted: June 6, 2010
Technology has transformed entire industries, from manufacturing and farming to media and marketing. So why has tech transformation eluded medicine, and medical education to be specific?
It's time we stop training doctors and surgeons in the same apprenticeship model that has been used for a hundred years. Despite many studies showing that surgeons need between 60 to 500 repetitions of a procedure to achieve proficiency, medical schools usually provide 10 to 20 repetitions on cadavers – with the rest of the training left up to supervised surgery.
Yet recent restrictions in allowed hospital hours mean that residents spend less time in patient encounters – and perhaps fall short of needed repetitions. We make pilots log hours in flight simulators; we should make surgeons go through similar training.
Cost is not a factor anymore Ten years ago, the cost of simulation technology for medical procedures may have been an impediment. Today, computational power has gone down in price and up in performance. Realistic graphics and haptics – the science of artificial touch -- make it possible for organizations using my company's haptic technology and others to build highly lifelike simulators that deliver multi-sensory experiences, including the exact sight, sounds and feelings of a procedure. For complete story click on .pdf file
Lessons Learned From Dennis Hopper’s Death June 4, 2010
Actor Dennis Hopper left behind a legacy of movie achievements when he died on May 29, 2010, at age 74 from prostate cancer.
He also left behind valuable life lessons about prostate cancer. Prostate cancer is a deadly disease that only afflicts men. In 2009, the American Cancer Society’s reported that there were 192,280 new cases of prostate cancer and 27,360 deaths in the United States. It is the second leading cause of cancer death in men, preceded by lung cancer and is the most common type of cancer for American men, besides skin cancer. It is estimated that one man out of every 6 will be diagnosed with prostate cancer during his lifetime, and one man out of every 35 will die from it.
Many people still think that prostate cancer is slow growing and doesn’t necessarily kill you. While it’s true that in some cases it’s slow growing, prostate cancer is still the 2nd leading cause of death in men. However, the news is not all bad. More than 2 million American men who have been diagnosed with prostate cancer are still alive today.
The death rate is going down, because it is being found earlier, thanks to education and awareness. Prostate cancer is very rare in men younger than 40, but if there is a family history, testing is advised. Cancer incidence only increases with age. African-American men are at a high risk for it and so are obese men....continue reading
Maurice Ferre, of Mako, and Professor Philip Rowe inspect the new robotic arm. Picture: Marc Turner
Surgeons use £1m robot arm to help in knee ops June 4, 2010
Surgeons at a Scottish hospital are using a robotic arm to carry out knee operations in a first for the UK.
It is hoped the technology will be more accurate than the traditional method, where the surgeons guide a saw, and ensure more operations are successful.
The robot is used to drill away bone damaged by osteoarthritis, making way for a replacement joint to be fitted. However, it does not make surgeons redundant in the operating theatre. They control the finger tip of the arm, which consists of a milling device, a little like a dentist’s drill. The drill is only powered when the tip is positioned over the area of bone which needs to be removed.
A computer running the robot uses co-ordinates from a CT scan of the diseased joint to determine where the drill will function. It also limits how deeply the surgeon can cut the bone away. Sensors are attached to bones in the knee so the computer knows exactly where it is at any time, meaning the joint can still be manipulated during the procedure.
The surgeon can watch where he is cutting on a computer screen showing the scan image, rather than looking down at the opening in the patient’s leg.
Mark Blyth, consultant orthopaedic surgeon at Glasgow Royal Infirmary, where the robot is in use, said: “We are very excited by this new technology which allows for highly accurate, sub-millimetre planing for part knee joint replacements."
Eight patients have been operated on using the robotic arm, which has been brought to Scotland from the United States....continue reading
Accuracy and speed trade-off in robot-assisted surgery Posted: June 4, 2010
Controlling surgical task speed and maintaining accuracy are vital components of robotic surgical skills. This study was designed to investigate the relationship between accuracy and speed for robot-assisted surgical skills.Ten participants were asked to alternately touch two circular targets with various dimensions and distances between two targets, using the da Vinci Surgical System.
The design of this study was based on Fitt's law. Statistical correlations between the index of difficulty (ID) and the movement time (MT), as well as the ID and the smoothness of the movement, were analysed...read more
Accuray Installs 200th CyberKnife Robotic Radiosurgery System June 3, 2010
Top Robotic Radiosurgery Device Celebrates Landmark Achievement as Growing Body of Clinical Evidence Helps Drive its Industry Leadership Position
SUNNYVALE, Calif., Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced the installation of the 200th CyberKnife® Robotic Radiosurgery System as continued evidence of its acceptance as the world's leading device for radiosurgery. The milestone system was installed at Mount Vernon Cancer Centre in the United Kingdom, the first hospital operated by the National Health Service (NHS) in the U.K. to acquire the CyberKnife device.
Accuray has made significant investment in the clinical and technology areas needed to support its high rate of growth. The total number of publications supporting CyberKnife System use increased from just over 50 publications in the beginning of 2002 to more than 430 publications currently. And as clinical evidence mounts, access to CyberKnife radiosurgery continues to accelerate. From the launch of the first commercially available CyberKnife System in 2003.....continue reading
Study links weight and prostate tumor size June 2, 2010
Blood test to detect tumors not as accurate in obese men.
Heavier men have bigger, more aggressive prostate tumors, according to new research from Henry Ford Hospital in Detroit presented today at a national urology meeting. The findings, based on a six-year study of metro Detroit men, show that the more a man weighed, the larger his prostate tumor.
The findings suggest that obese men should more routinely undergo a test called a digital rectal exam, performed by a doctor wearing a glove, because a blood test used to find prostate cancer is not as accurate in heavier men, said Dr. Nilesh Patil...read more
Single-Incision Laparoendoscopic Surgery Appears Similar to Multiport Procedures: Presented at AUA SAN FRANCISCO, June 2, 2010
Surgery requiring just a small incision often hidden within a patient's navel appears to be as successful as multiport laparoendoscopic surgical procedures, researchers reported at the 2010 American Urological Association (AUA) Annual Meeting.
"Perioperative and early postoperative outcomes demonstrate that laparoendoscopic single-site [LESS] surgery is feasible and safe for a broad range of urological procedures, given a careful patient selection," explained Jihad Kaouk, MD, Cleveland Clinic, Cleveland, Ohio, speaking at a poster presentation on May 31.
Dr. Kaouk said the procedure appears to offer the greatest success with the least risk of serious adverse events (barring certain patients, especially those with a body mass index higher than 30)....read more
Immersion Expands Presence in High-Growth Robotic Surgery Market June 2, 2010
SOFAR Licenses TouchSense(R) Haptics to Power Feedback in Remote Console for Innovative Surgical System
(BUSINESS WIRE) -- Immersion Corporation (IMMR 5.21, +0.23, +4.62%) , the leading developer and licensor of haptics technology, today announced that SOFAR S.p.A., a leading Italian manufacturer of medical devices for minimally invasive surgery, has obtained a license to Immersion's TouchSense haptics technology for use in its ALF-X (Advanced Laparoscopy through Force Reflection) telesurgical robot system.
TouchSense will provide haptic feedback in the cockpit/console from which surgeons control and manipulate the system, engaging the sense of touch to assist in device navigation and laparoscopic procedures. The license represents momentum for Immersion in the growing robotics surgery market.
SOFAR developed ALF-X in conjunction with the European Commission's Joint Research Centre (JRC). The system employs a range of features covering tactile sensing capabilities, versatility, safety and ease of use to improve the quality of laparoscopic surgical procedures. ALF-X is intended for use in hospitals, universities, medical training center and research organizations worldwide....read more
Transobturator Retroluminal Repositioning Sling Shows Good Outcomes at 1 Year for Male Urinary Stress Incontinence: Presented at AUA June 1, 2010
Men with mild to moderate stress incontinence following prostatectomy may find relief with a transobturator retroluminal repositioning sling, researchers said at the 2010 American Urological Association (AUA) Annual Meeting.
"We examined 1 year of data on 118 patients with the sling," said Peter Rehder, MD, Medical University Innsbruck, Innsbruck, Austria, on May 31.
"We found that the patients who were best suited for this repositioning sling had an uncomplicated radical prostatectomy with no other treatments and mild to moderate incontinence. The correct positioning of the middle piece of the sling is critical for a good outcome."...continue reading
Surgeon/Engineer Team Produces World’s First Procedure-Based Training Software for Robot-Assisted Surgery June 1, 2010
Newswise — Two Buffalo scientists have paired up to create technology that has the potential to revolutionize surgical training worldwide, developing the first procedure-based, hands-on surgical training software.
Their patent-pending system, Hands-On Surgical Training ™ (HOST), guides surgeons through real-time operative procedures using the Robotic Surgical Simulator ™ (RoSS) interface.
Khurshid Guru, MD, a staff physician in Urology at Roswell Park Cancer Institute (RPCI), and Thenkurussi “Kesh” Kesavadas, PhD, director of the Virtual Reality Laboratory and a professor of mechanical and aerospace engineering at the University at Buffalo (UB), created RoSS as a way to help surgeons hone their skills in robot-assisted surgery so that they’ve logged hours of training before they perform a particular surgical procedure. The HOST software system takes this concept further, immersing the surgeon in a surgical environment using automation technology and an interactive checklist-based process.
“It’s as close to operating as you can get outside the operating room,” says Dr. Guru, who is also director of RPCI’s Center for Robotic Surgery. “HOST literally holds the surgeon’s hands.”
The HOST software system takes surgeons through surgical steps, prompting and guiding them through the critical stages of an operation before proceeding to the next step. A metrics tool evaluates user performance so that surgeons can track their progress.
That step-by-step prompting system is unique in the field of computer-assisted surgical learning tools, as is HOST’s basis in observational learning. It’s an extremely effective system for training surgeons on emerging robot-assisted surgical techniques, says Dr. Guru.....read more
Robotic Urologic Surgery-Mayo Clinic June 1, 2010
Benign prostate hyperplasia, or BPH, is a common condition that men develop as they age. The main symptom is the need to make frequent trips to the bathroom. In extreme cases, complications such as painful bladder stones can develop. Traditional treatment for these cases meant a big incision and several days in the hospital. But now doctors are using minimally invasive robots to perform this operation. Let’s go to Mayo Clinic to find out what the technology means for patients.
Cyberknife Radiosurgery System June 1, 2010
Invented by John R. Adler, Professor of Radiation and Neurosurgery at Stanford University as well as Peter and Russell Schonberg of Schonberg University, cyber knife treatments are based on the principles of radiosurgery. This robotic surgery is a noninvasive surgery that treats cancerous as well as benign tumors. Cyberknife surgery uses radiation in extreme doses and with careful precision to treat the cancer cells.
Benefits of cyberknife treatments: • Minimal complications compaired to invasive surgical methods • Cyberknife surgery does not include the use of metal frames and skull pins • Recovery time is not required with this form of surgery. • Cyberknife treatment greatly reduces the risk of the surrounding healthy tissues getting damaged during treatment • It can reach complex tumors that were previously considered difficult to operate or even inoperable • Cyberknife surgery is less painful and does not require strong sedation.....read more
Any medical information published on this website is intended purely as a informational tool only and is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.
The Copyright of all images and documents is by the According Developing Group, Institute, Editor or Company. We only included data and images freely accessible. We have linked each image and/or story back to it's original source. If you want your system or certain information on it removed from our website, please contact us at email@example.com